Journal of Allergy and Clinical Immunology-In Practice

Article	Citations
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach	332
A Consensus Approach to the Primary Prevention of Food Allergy Through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immuno	193
Chronic Rhinosinusitis with Nasal Polyps and Asthma	190
US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema	177
Polyethylene Glycol–Induced Systemic Allergic Reactions (Anaphylaxis)	154
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach	154
Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients	117
Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis	114
Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness	114
Long-Term Therapy Response to Anti–IL-5 Biologics in Severe Asthma—A Real-Life Evaluation	112
Pediatric Asthma Health Care Utilization, Viral Testing, and Air Pollution Changes During the COVID-19 Pandemic	105
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing	103
Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis	98
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis	97
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis	89
The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells	86
Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis	86
Anti-PEG IgE in anaphylaxis associated with polyethylene glycol	85
Clinical Relevance of Cross-Reactivity in Food Allergy	82
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process	80
Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS)	80
Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect	80
Improving Diagnostic Accuracy in Food Allergy	79
Real-World Effectiveness of Omalizumab in Severe Allergic Asthma: A Meta-Analysis of Observational Studies	79
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which	77

Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes	73
Hereditary Alpha-Tryptasemia: UK Prevalence and Variability in Disease Expression	73
Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors	73
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma	68
Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City	68
Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years	65
Impact of Allergic Rhinitis and Asthma on COVID-19 Infection, Hospitalization, and Mortality	65
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study	63
Complications of switching from anti–IL-5 or anti–IL-5R to dupilumab in corticosteroid-dependent severe asthma	62
Digital Health Technology in Asthma: A Comprehensive Scoping Review	62
Trends in hospitalizations for asthma during the COVID-19 outbreak in Japan	61
Reduction of allergic rhinitis symptoms with face mask usage during the COVID-19 pandemic	61
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry	61
Rhinovirus Infections and Their Roles in Asthma: Etiology and Exacerbations	60
The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma	59
COVID-19 Susceptibility in Bronchial Asthma	58
Immunological Responses and Biomarkers for Allergen-Specific Immunotherapy Against Inhaled Allergens	57
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity	57
An Approach to the Office-Based Practice of Food Oral Immunotherapy	56
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps	55
Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and Anaphylaxis	54
Prevalence and Burden of Chronic Cough in the United States	53
Which Are the Optimal Criteria for the Diagnosis of Allergic Bronchopulmonary Aspergillosis? A Latent Class Analysis	52
Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era	51
Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection	51
Geospatial Analysis of Social Determinants of Health Identifies Neighborhood Hot Spots Associated With Pediatric Intensive Care Use for Life-Threatening Asthma	50
Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies	49
Potential Severe Asthma Hidden in UK Primary Care	49
Diagnostic Delay in Patients with Eosinophilic Gastritis and/or Duodenitis: A Population-Based Study	49
Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions	49
Dupilumab Improves Asthma Control and Lung Function in Patients with Insufficient Outcome During Previous Antibody Therapy	48
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps	48
Autoimmune Chronic Spontaneous Urticaria Detection with IgG Anti-TPO and Total IgE	47
2020 NAEPP Guidelines Update and GINA 2021—Asthma Care Differences, Overlap, and Challenges	46
Small Airway Dysfunction Links Asthma Severity with Physical Activity and Symptom Control	46
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study	45
Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak	45
The Impact of Patient Self-Monitoring Via Electronic Medication Monitor and Mobile App Plus Remote Clinician Feedback on Adherence to Inhaled Corticosteroids: A Randomized Controlled Trial	45
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America	45
Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis	44
Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study	43
First Real-World Effectiveness Analysis of Preschool Peanut Oral Immunotherapy	43
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19	42
A Practical Guide to Implementing SMART in Asthma Management	42
Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-Analysis	41
Penicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use	41
Asthma and Three Colinear Comorbidities: Obesity, OSA, and GERD	41
The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia	41
Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease	40
Lower Use of Biologics for the Treatment of Asthma in Publicly Insured Individuals	40

Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis	40
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series	40
Basophil Activation Test Reduces Oral Food Challenges to Nuts and Sesame	40
Translating Evidence to Optimize Patient Care Using GRADE	40
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma	40
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice	39
Age-Related Differences in Immunological Responses to SARS-CoV-2	39
The Expanding Spectrum of Mutations in Hereditary Angioedema	39
Bringing the Next Generation of Food Allergy Diagnostics Into the Clinic	39
Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis	38
COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach	38
FEF25-75% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF25-75% and FEV1%	37
Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets	37
SARS-CoV-2 Vaccines: Where Are We Now?	37
Advancing Food Allergy Through Epidemiology: Understanding and Addressing Disparities in Food Allergy Management and Outcomes	37
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium	37
Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies	37
Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion	37
Innate and Adaptive Immunity: ILC2 and Th2 Cells in Upper and Lower Airway Allergic Diseases	37
Appraisal of the Real-World Effectiveness of Biologic Therapies in Aspirin-Exacerbated Respiratory Disease	37
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results	37
Targeting Downstream Type 2 Cytokines or Upstream Epithelial Alarmins for Severe Asthma	36
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review	36
Managing Food Allergy When the Patient Is Not Highly Allergic	36
REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma	36
The Relationship of Asthma Biologics to Remission for Asthma	36
Risk Factors and Characteristics of Biphasic Anaphylaxis	35
Treatable Traits That Predict Health Status and Treatment Response in Airway Disease	35
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab	35
Hypogammaglobulinemia After Chimeric Antigen Receptor (CAR) T-Cell Therapy: Characteristics, Management, and Future Directions	35
Risk of Psychiatric Adverse Events Among Montelukast Users	34
A Randomized, Open-Label Trial of Hen's Egg Oral Immunotherapy: Efficacy and Humoral Immune Responses in 50 Children	34
Pragmatic Clinical Perspective on Biologics for Severe Refractory Type 2 Asthma	34
Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases	34
Personalized Treatment of Asthma: The Importance of Sex and Gender Differences	34
Current Use of Probiotics and Prebiotics in Allergy	34
Effect of COVID-19 on asthma exacerbation	34
Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population	34
Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma	34
Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience	34
Cigarette Smoking and Asthma	33
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus	33
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic Dermatitis	33
Comparison of Nonesophageal Eosinophilic Gastrointestinal Disorders with Eosinophilic Esophagitis: A Nationwide Survey	33
AAAAI Work Group Report: Trends in Oral Food Challenge Practices Among Allergists in the United States	32
Recent dramatic increase in patients with food protein–induced enterocolitis syndrome (FPIES) provoked by hen’s egg in Japan	32
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis	32
Establishing Amoxicillin Allergy in Children Through Direct Graded Oral Challenge (GOC): Evaluating Risk Factors for Positive Challenges, Safety, and Risk of Cross-Reactivity to Cephalosporines	32
Early Discontinuation of Cow's Milk Protein Ingestion Is Associated with the Development of Cow's Milk Allergy	32
COVID-19 infection in 10 common variable immunodeficiency patients in New York City	31
Personalized Medication Adherence Management in Asthma and Chronic Obstructive Pulmonary Disease: A Review of Effective Interventions and Development of a Practical Adherence Toolkit	31
New Perspectives on Difficult Asthma; Sex and Age of Asthma-Onset Based Phenotypes	31
Peanut-induced food protein–induced enterocolitis syndrome (FPIES) in infants with early peanut introduction	31
Treatable Traits in Airway Disease: From Theory to Practice	31
Pediatric asthma exacerbations during the COVID-19 pandemic: Absence of the typical fall seasonal spike in Washington, DC	31
Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis–Based Comparison	31
Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food	31
A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy—One Epinephrine Autoinjector or Two?	31
The Accuracy of Diagnostic Testing in Determining Tree Nut Allergy: A Systematic Review	30
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial Allergy	30
The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions	30
Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy	30
COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency	30
Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial	30
The Psychosocial Burden of Food Allergy Among Adults: A US Population-Based Study	30
Oral Corticosteroids and Risk of Preterm Birth in the California Medicaid Program	30
Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic Review	30
Food Proteins in Human Breast Milk and Probability of IgE-Mediated Allergic Reaction in Children During Breastfeeding: A Systematic Review	30
Patient Satisfaction with In-Person, Video, and Telephone Allergy/Immunology Evaluations During the COVID-19 Pandemic	30
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score	29
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma	29
Biologicals and Endoscopic Sinus Surgery for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps: An Economic Perspective	29
Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use	29
The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity	29
A Systematic Review of the Effect of Physical Activity on Asthma Outcomes	29
Preventive Effect of Allergen Immunotherapy on Asthma and New Sensitizations	29
Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines	29
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)	29
COVID-19 Pandemic–Related Reductions in Pediatric Asthma Exacerbations Corresponded with an Overall Decrease in Respiratory Viral Infections	28
The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World	28

Sleep Disturbance in School-Aged Children with Atopic Dermatitis: Prevalence and Severity in a Cross-Sectional Sample	28
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)	28
Improvement in Health-Related Quality of Life in Food-Allergic Patients: A Meta-Analysis	28
Disparities in Asthma and Allergy Care: What Can We Do?	28
How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit	28
Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma	28
Food-Induced Anaphylaxis in Infants: Can New Evidence Assist with Implementation of Food Allergy Prevention and Treatment?	27
Direct Challenges for the Evaluation of Beta-Lactam Allergy: Evidence and Conditions for Not Performing Skin Testing	27
Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry	27
Characterization of Asthma Trajectories from Infancy to Young Adulthood	27
Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort	27
Glycated Hemoglobin A1c, Lung Function, and Hospitalizations Among Adults with Asthma	27
The Diagnostic Workup in Chronic Spontaneous Urticaria—What to Test and Why	27
Quantification of Glucocorticoid-Associated Morbidity in Severe Asthma Using the Glucocorticoid Toxicity Index	27
Ten Rules for Implementation of a Telemedicine Program to Care for Patients with Asthma	27
Cost-Effectiveness of Biologics for Allergic Diseases	26
Most Patients With Autoimmune Chronic Spontaneous Urticaria Also Have Autoallergic Urticaria, but Not Vice Versa	26
Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination	26
Chronic Spontaneous Urticaria: The Role and Relevance of Autoreactivity, Autoimmunity, and Autoallergy	26
Food Protein–Induced Enterocolitis Syndrome in Adulthood: Clinical Characteristics, Prognosis, and Risk Factors	26
Vaccine Hesitancy: Drivers and How the Allergy Community Can Help	26
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases	26
DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case Series	26
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group	26
Food Insecurity in the Food Allergic Population: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee	26
A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies	26
Ten Years of Newborn Screening for Severe Combined Immunodeficiency (SCID) in Massachusetts	25
Peanut Can Be Used as a Reference Allergen for Hazard Characterization in Food Allergen Risk Management: A Rapid Evidence Assessment and Meta-Analysis	25
Omalizumab Is an Effective Intervention in Severe Asthma with Fungal Sensitization	25
African American Children Are More Likely to Be Allergic to Shellfish and Finfish: Findings from FORWARD, a Multisite Cohort Study	25
Assessment and Management of Occupational Asthma	25
Benralizumab for severe DRESS in two COVID-19 patients	25
Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting	25
Synchronous Telemedicine in Allergy: Lessons Learned and Transformation of Care During the COVID-19 Pandemic	25
Effectiveness of a Digital Inhaler System for Patients With Asthma: A 12-Week, Open-Label, Randomized Study (CONNECT1)	25
Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent Asthma	25
Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center Study	25
Cell-Based Functional IgE Assays Are Superior to Conventional Allergy Tests for Shrimp Allergy Diagnosis	25
Prevalence of asthma in hospitalized and non-hospitalized children with COVID-19	25
Asthma Disparities During the COVID-19 Pandemic: A Survey of Patients and Physicians	24
Prevalence of Physician-Reported Food Allergy in Canadian Children	24
Testing Strategies and Predictors for Evaluating Immediate and Delayed Reactions to Cephalosporins	24
Clinical Outcomes in People with Difficult-to-Control Asthma Using Electronic Monitoring to Support Medication Adherence	24
A Framework for Augmented Intelligence in Allergy and Immunology Practice and Research—A Work Group Report of the AAAAI Health Informatics, Technology, and Education Committee	24
Targeting Skin Barrier Function in Atopic Dermatitis	24
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma	24
Natural History of IgE-Mediated Fish Allergy in Children	24
“COVID Arm”: Very delayed large injection site reactions to mRNA COVID-19 vaccines	24
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases	24
Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System	24
Successful pregnancy in the setting of eosinophil depletion by benralizumab	24
Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study	24
Practical Challenges and Considerations for Early Introduction of Potential Food Allergens for Prevention of Food Allergy	24
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study	24
Urticaria: The 1-1-1 Criterion for Optimized Risk Stratification in β-Lactam Allergy Delabeling	24
Management of Severe Atopic Dermatitis in Pediatric Patients	23
Management of Asthma Exacerbations in the Emergency Department	23
Adult and Pediatric Food Allergy to Chickpea, Pea, Lentil, and Lupine: A Scoping Review	23
The Association of Asthma With COVID-19 Mortality: An Updated Meta-Analysis Based on Adjusted Effect Estimates	23
Variability in Blood Eosinophil Counts in Patients with Eosinophilic Asthma	23
Walnut Allergy Across Europe: Distribution of Allergen Sensitization Patterns and Prediction of Severity	23
Real-world peanut OIT in infants may be safer than non-infant preschool OIT and equally effective	23
Characterization of Asthma by Age of Onset: A Multi-Database Cohort Study	23
Comparative Efficacy and Acceptability of Licensed Dose Second-Generation Antihistamines in Chronic Spontaneous Urticaria: A Network Meta-Analysis	23
Atopic Dermatitis and Food Allergy: Best Practices and Knowledge Gaps—A Work Group Report from the AAAAI Allergic Skin Diseases Committee and Leadership Institute Project	23
Vancomycin Hypersensitivity Reactions Documented in Electronic Health Records	23
Patient-Reported Burden of Chronic Cough in a Managed Care Organization	23
Controversies in Allergy: Choosing a Biologic for Patients with Severe Asthma	23
One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future	23
Patients’ and Caregivers’ Experiences With Atopic Dermatitis–Related Burden, Medical Care, and Treatments in 8 Countries	22
Real-World Effectiveness of Anti–IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization	22
Metformin Use and Risk of Asthma Exacerbation Among Asthma Patients with Glycemic Dysfunction	22
The Psychosocial Impact of Food Protein-Induced Enterocolitis Syndrome	22
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase	22
Differentiating Between β-Lactam-Induced Serum Sickness–Like Reactions and Viral Exanthem in Children Using a Graded Oral Challenge	22
Trends in US Emergency Department Visits for Anaphylaxis Among Infants and Toddlers: 2006-2015	22
The Clinical Implications of Aspergillus Fumigatus Sensitization in Difficult-To-Treat Asthma Patients	22
Impact of a Decade of Research Into Atopic Dermatitis	22
Social Determinants of Health in Asthma Through the Life Course	22
Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions	22
Acute At-Home Management of Anaphylaxis: 911: What Is the Emergency?	22
Real-world adoption of FDA-approved peanut oral immunotherapy with palforzia	22
Epidemic Thunderstorm Asthma: Lessons Learned from the Storm Down-Under	22
PEG/Polysorbate Skin Testing Has No Utility in the Assessment of Suspected Allergic Reactions to SARS-CoV-2 Vaccines	22
Peak Inspiratory Flow Measured at Different Inhaler Resistances in Patients with Asthma	22
Asthma Remission by Age at Diagnosis and Gender in a Population-Based Study	22
An Online Weight Loss Intervention for People With Obesity and Poorly Controlled Asthma	22
The Natural Course of Adult-Onset Food Protein-Induced Enterocolitis Syndrome	21
Hypereosinophilia with systemic manifestations under dupilumab and possibility of dual benralizumab and dupilumab therapy in patients with asthma and CRSwNP	21
Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health	21
Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine	21
COVID-19 Infections and Asthma	21
Increased disinfectant use among adults with asthma in the era of COVID-19	21
Intranasal Corticosteroids Are Associated with Better Outcomes in Coronavirus Disease 2019	21
Delayed and Severe Reactions to Baked Egg and Baked Milk Challenges	21